These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 8091903)
1. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology. Granados R; Cibas ES; Fletcher JA Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903 [TBL] [Abstract][Full Text] [Related]
2. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis. Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350 [TBL] [Abstract][Full Text] [Related]
3. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Sherman ME; Mark EJ Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659 [TBL] [Abstract][Full Text] [Related]
4. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens. Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412 [TBL] [Abstract][Full Text] [Related]
5. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Illei PB; Ladanyi M; Rusch VW; Zakowski MF Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646 [TBL] [Abstract][Full Text] [Related]
6. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma. Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380 [TBL] [Abstract][Full Text] [Related]
7. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma. Shin HJ; Shin DM; Tarco E; Sneige N Cancer; 2003 Aug; 99(4):233-9. PubMed ID: 12925985 [TBL] [Abstract][Full Text] [Related]
8. Chromosome analysis in effusions as a diagnostic adjunct to cytology. Augustus M; Visveshwara RN; Bhargava MK Indian J Cancer; 1989 Jun; 26(2):67-75. PubMed ID: 2592000 [TBL] [Abstract][Full Text] [Related]
9. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy. Kobzik L; Antman KH; Warhol MJ Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121 [TBL] [Abstract][Full Text] [Related]
10. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect]. Marsan C; Gaulier A; Sabatier P; Garcia R Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583 [TBL] [Abstract][Full Text] [Related]
11. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
12. The potential value of comparative genomic hybridization analysis in effusion-and fine needle aspiration cytology. Nagel H; Schulten HJ; Gunawan B; Brinck U; Füzesi L Mod Pathol; 2002 Aug; 15(8):818-25. PubMed ID: 12181266 [TBL] [Abstract][Full Text] [Related]
13. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969 [TBL] [Abstract][Full Text] [Related]
14. [Peritoneal cytology]. Courtade-Saïdi M; d'Aure D; Quintyn-Ranty ML Ann Pathol; 2009 Nov; 29 Spec No 1():S118-9. PubMed ID: 19887240 [No Abstract] [Full Text] [Related]
15. Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: a case report. Pomjanski N; Grote HJ; Sander O; Heikaus S; Müller KM; Böcking A Diagn Cytopathol; 2008 Feb; 36(2):120-3. PubMed ID: 18181185 [TBL] [Abstract][Full Text] [Related]
16. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Ong KC; Indumathi V; Poh WT; Ong YY Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675 [TBL] [Abstract][Full Text] [Related]
17. Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes. Motherby H; Marcy T; Hecker M; Ross B; Nadjari B; Auer H; Müller KM; Häussinger D; Strauer BE; Böcking A Anal Quant Cytol Histol; 1998 Jun; 20(3):153-61. PubMed ID: 9642441 [TBL] [Abstract][Full Text] [Related]
18. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions. Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442 [TBL] [Abstract][Full Text] [Related]
19. Image cytometry: an aid for cytological diagnosis of pleural effusions. Osterheld MC; Liette C; Anca M Diagn Cytopathol; 2005 Mar; 32(3):173-6. PubMed ID: 15690335 [TBL] [Abstract][Full Text] [Related]
20. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]